Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 2 pages · Chinese
Earlier from Getein Biotech
- Announcement on Outline of the Q3 2025 Online Performance Briefing
- Report for Q3 2025
- Announcement on Completing Industrial and Commercial Change Registration and Filing and Obtaining the Business License
- Announcement on Progress in Litigation Involving the Company
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
Later from Getein Biotech
- Announcement on Resignation of Secretary of Board of Directors
- Announcement on Resignation of the Securities Affairs Representative
- Announcement on Adjustment of Partial Members of the Special Committee of the Board of Directors
- Announcement on Appointing the Secretary of the Board of Directors
- and Transfer of Equity in the Holding Subsidiary
Follow Getein Biotech into a list and get an email when it puts out news.
Follow Getein Biotech